Breaking News

ChemPartner Expands Biologics Capabilities

Makes additional investments in biologics from research to manufacturing capabilities

By: Contract Pharma

Contract Pharma Staff

Shanghai ChemPartner has made additional investments into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing.   “ChemPartner has rich experience in providing biologics discovery and development services,” said Wei Tang, chief executive officer, ChemPartner. “Our exceptional scientists on our biologics discovery and development teams provide one-stop services for overall process development and IND ap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters